×
Vaso Total Long-Term Assets 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Vaso total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
View More
Vaso Total Long-Term Assets 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Vaso total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$202.3B
Intuitive Surgical (ISRG)
$191.3B
Edwards Lifesciences (EW)
$44.5B
Alcon (ALC)
$42.5B
IQVIA Holdings (IQV)
$36.3B
IDEXX Laboratories (IDXX)
$33.9B
DexCom (DXCM)
$31.3B
Waters (WAT)
$22.2B
STERIS (STE)
$20.6B
SONOVA HOLDING (SONVY)
$19.8B
Hologic (HOLX)
$16.5B
Fresenius Medical Care AG KGaA (FMS)
$13.3B
Sysmex ADR (SSMXY)
$11.7B
Globus Medical (GMED)
$11.4B
Penumbra (PEN)
$9.2B
Masimo (MASI)
$9B
Glaukos (GKOS)
$8.3B
Teleflex (TFX)
$8.2B
Integer Holdings (ITGR)
$4.5B
PROCEPT BioRobotics (PRCT)
$4.4B
Veracyte (VCYT)
$3.2B
Inari Medical (NARI)
$3.1B
LivaNova (LIVN)
$2.5B
Tandem Diabetes Care (TNDM)
$2.4B
Nihon Kohden (NHNKY)
$2.4B
TransMedics (TMDX)
$2.1B
Elekta AB (EKTAY)
$2B
Integra LifeSciences Holdings (IART)
$1.7B
RxSight (RXST)
$1.4B
Alphatec Holdings (ATEC)
$1.3B